HomeANIX • NASDAQ
add
Anixa Biosciences Inc
Previous close
$3.15
Day range
$3.11 - $3.17
Year range
$2.07 - $4.20
Market cap
101.42M USD
Avg Volume
95.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.39M | -6.18% |
Net income | -3.18M | 2.18% |
Net profit margin | — | — |
Earnings per share | -0.10 | 0.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.26M | -27.49% |
Total assets | 18.91M | -25.48% |
Total liabilities | 2.19M | 24.04% |
Total equity | 16.71M | — |
Shares outstanding | 32.19M | — |
Price to book | 5.73 | — |
Return on assets | -41.81% | — |
Return on capital | -46.95% | — |
Cash Flow
Net change in cash
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -3.18M | 2.18% |
Cash from operations | -2.90M | -25.77% |
Cash from investing | 2.70M | 1,995.35% |
Cash from financing | -17.00K | -100.75% |
Net change in cash | -218.00K | -362.65% |
Free cash flow | -1.55M | -23.12% |
About
Founded
1982
Headquarters
Website
Employees
5
